Molecular analyses define Va7.2-Ja33+ MAIT cell depletion in HIV Infection: A case-control study

Medicine (United States)

Volumn 94, Issue 29, 2015, Pages

  Ussher, James E ^a,b   Phalora, Prabhjeet ^a   Cosgrove, Cormac ^a,c   Hannaway, Rachel F ^b   Rauch, Andri ^d   Gunthard, Huldrych F ^e   Goulder, Philip ^a   Phillips, Rodney E ^a   Willberg, Christian B ^a   Klenerman, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MUCOSAL ASSOCIATED INVARIANT T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL DEPLETION; T LYMPHOCYTE; VIRUS LOAD; BLOOD; METABOLISM; NATURAL KILLER T CELL;

ADULT; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84942426328     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001134     Document Type: Article

References (35)

1. Dusseaux M, Martin E, Serriari N, et al. Human MAIT cells are xenobiotic-resistant, tissue-Targeted, CD161hi IL-17-secreting T cells. Blood. 2011;117:1250-1259.
2. Treiner E, Duban L, Bahram S, et al. Selection of evolutionarily conserved mucosal-Associated invariant T cells by MR1. Nature. 2003;422:164-169.
3. Martin E, Treiner E, Duban L, et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 2009;7:e1000054.
4. Kjer-Nielsen L, Patel O, Corbett AJ, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491:717-723.
5. Corbett AJ, Eckle SBG, Birkinshaw RW, et al. T-cell activation by transitory neo-Antigens derived from distinct microbial pathways. Nature. 2014;509:361-365.
6. Gold MC, Cerri S, Smyk-Pearson S, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 2010;8:e1000407.
7. Le Bourhis L, Martin E, Péguillet I, et al. Antimicrobial activity of mucosal-Associated invariant T cells. Nat Immunol. 2010;11:701-708.
8. Chua W-J, Truscott SM, Eickhoff CS, et al. Polyclonal mucosaassociated invariant T cells have unique innate functions in bacterial infection. Infect Immun. 2012;80:3256-3267.
9. Tilloy F, Treiner E, Park S-H, et al. An invariant T cell receptor a chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted a/b T cell subpopulation in mammals. J Exp Med. 1999;189:1907-1921.
10. Reantragoon R, Corbett AJ, Sakala IG, et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-Associated invariant T cells. J Exp Med. 2013;210:2305-2320.
11. Walker LJ, Kang Y-H, Smith MO, et al. Human MAIT and CD8aa cells develop from a pool of type-17 precommitted CD8+ T cells. Blood. 2012;119:422-433.
12. Ussher JE, Bilton M, Attwod E, et al. CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+ IL-18 in a TCR-independent manner. Eur J Immunol. 2014;44:195-203.
13. Cosgrove C, Ussher JE, Rauch A, et al. Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood. 2013;121:951-961.
14. Leeansyah E, Ganesh A, Quigley MF, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT cell population in chronic HIV-1 infection. Blood. 2013;121:1124-1135.
15. Wong EB, Akilimali NA, Govender P, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One. 2013;8:e83474.
16. Gaardbo JC, Hartling HJ, Thorsteinsson K, et al. CD3+ CD8+ CD161 high Tc17 cells are depleted in HIV-infection. Aids. 2013;27:659-662.
17. Fernandez CS, Amarasena T, Kelleher AD, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-188.
18. Eberhard JM, Hartjen P, Kummer S, et al. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIVinfected individuals independently of disease progression. PLoS One. 2014;9:e111323.
19. Prendergast A, Prado JG, Kang Y-H, et al. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS. 2010;24:491-502.
20. Bucci C, von Delft A, Christian A, et al. Favourable IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype 3a infection and do not predict a sustained virological response after 24 weeks of therapy. J Gen Virol. 2013;94:1259-1265.
21. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 2002;109:S45-S55.
22. Lee OJ, Cho Y-N, Kee S-J, et al. Circulating mucosal-Associated invariant T cell levels and their cytokine levels in healthy adults. Exp Gerontol. 2014;49:47-54.
23. Kurioka A, Ussher JE, Cosgrove C, et al. MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol. 2015;8:429-440.
24. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371.
25. Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010;6:e1001052.
26. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-Treated HIV infection. J Infect Dis. 2009;199:1177-1185.
27. Greathead L, Metcalf R, Gazzard B, et al. CD8+/CD161++ mucosal-Associated invariant T-cell levels in the colon are restored on long-Term antiretroviral therapy and correlate with CD8+ T-cell immune activation. AIDS. 2014;28:1690-1692.
28. Schneider T, Ullrich R, Bergs C, et al. Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. Clin Exp Immunol. 1994;95:430-435.
29. Lim SG, Condez A, Lee CA, et al. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol. 1993;92:448-454.
30. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol. 2003;77:11708-11717.
31. Lepore M, Kalinichenko A, Colone A, et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRb repertoire. Nat Commun. 2014;5:3866.
32. Georgel P, Radosavljevic M, Macquin C, et al. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol Immunol. 2011;48:769-775.
33. Meierovics A, Yankelevich W-JC, Cowley SC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci USA. 2013;110:E3119-E3128.
34. Sonnenberg P, Glynn JR, Fielding K, et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis. 2005;191:150-158.
35. Gordon MA, Walsh AL, Chaponda M, et al. Bacteraemia and mortality among adult medical admissions in Malawi-predominance of non-Typhi Salmonellae and Streptococcus pneumoniae. J Infect. 2001;42:44-49.